Randomized Clinical Trial to Study the Effect of Extended Release Niacin on Endothelial Function, Oxidative Stress and Endothelial Progenitor Cells in Patients With the Metabolic Syndrome
Phase of Trial: Phase IV
Latest Information Update: 21 Dec 2009
At a glance
- Drugs Niacin (Primary)
- Indications Metabolic syndrome
- Focus Pharmacodynamics
- Acronyms High-Ennd
- 05 May 2008 Actual patient number from clinicaltrials.gov record is 32.
- 08 Jan 2008 New trial record.